1. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010; 362:1597–1604.
2. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992; 87:1716–1727.
3. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA. 1994; 272:65–69.
4. Graham JR. Helicobacter pylori: human pathogen or simply an opportunist? Lancet. 1995; 345:1095–1097.
5. Cho DK, Park SY, Kee WJ, et al. The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy. Korean J Gastroenterol. 2010; 55:368–375.
6. Lee JY, Kim N. Future trends of Helicobacter pylori eradication therapy in Korea. Korean J Gastroenterol. 2014; 63:158–170.
7. Lee JY, Kim N, Kim MS, et al. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. Dig Dis Sci. 2014; 59:1235–1243.
8. Cho JY, Chang HJ, Lee SK, Kim HJ, Hwang JK, Chun HS. Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene. Life Sci. 2007; 80:932–939.
9. Klauke AL, Racz I, Pradier B, et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. Eur Neuropsychopharmacol. 2014; 24:608–620.
10. Singh G, Marimuthu P, de Heluani CS, Catalan CA. Antioxidant and biocidal activities of Carum nigrum (seed) essential oil, oleoresin, and their selected components. J Agric Food Chem. 2006; 54:174–181.
11. Dahham SS, Tabana YM, Iqbal MA, et al. The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of aquilaria crassna. Molecules. 2015; 20:11808–11829.
12. Kubo I, Chaudhuri SK, Kubo Y, et al. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Med. 1996; 62:427–430.
13. Pichette A, Larouche PL, Lebrun M, Legault J. Composition and antibacterial activity of Abies balsamea essential oil. Phytother Res. 2006; 20:371–373.
14. Fantaye CA, Köpke D, Gershenzon J, Degenhardt J. Restoring (E)-β-caryophyllene production in a non-producing maize line compromises its resistance against the fungus colletotrichum graminicola. J Chem Ecol. 2015; 41:213–223.
15. Oh MS, Yang JY, Kim MG, Lee HS. Acaricidal activities of β-caryophyllene oxide and structural analogues derived from Psidium cattleianum oil against house dust mites. Pest Manag Sci. 2014; 70:757–762.
16. Ashitani T, Kusumoto N, Borg-Karlson AK, Fujita K, Takahashi K. Antitermite activity of beta-caryophyllene epoxide and episulfide. Z Naturforsch C. 2013; 68:302–306.
17. Bahi A, Al Mansouri S, Al Memari E, Al Ameri M, Nurulain SM, Ojha S. β-caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav. 2014; 135:119–124.
18. Chang HJ, Kim JM, Lee JC, Kim WK, Chun HS. Protective effect of β-caryophyllene, a natural bicyclic sesquiterpene, against cerebral ischemic injury. J Med Food. 2013; 16:471–480.
19. Yamaguchi M, Levy RM. The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro. Int J Mol Med. 2016; 38:1940–1946.
20. Cheng Y, Dong Z, Liu S. β-caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014; 94:1–12.
21. de Oliveira CC, de Oliveira CV, Grigoletto J, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016; 56:26–31.
22. Sain S, Naoghare PK, Devi SS, et al. Beta caryophyllene and caryophyllene oxide, isolated from Aegle marmelos, as the potent anti-inflammatory agents against lymphoma and neuroblastoma cells. Antiinflamm Antiallergy Agents Med Chem. 2014; 13:45–55.
23. Huang FY, Chan AO, Lo RC, et al. Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-/-)) mice. Eur J Cancer. 2013; 49:2760–2770.